about
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancerCyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.Implications on laboratory workload of breast cancer screening.Laboratory handling of impalpable breast lesions: a reviewExpression of MUC2 epithelial mucin in breast carcinoma.The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression
P2860
Q35588327-BACA126C-58F9-49FD-B8E3-242C11D77C4DQ36134760-D59DE1F5-762A-42BF-A606-FFF6313CF82FQ36643848-DDD2B704-5BC3-403B-BD90-E6526EA9C245Q37111468-B5EB678A-3562-43BD-9ACD-FBE9697899C8Q37144665-10FE7DC6-711D-4A8C-94C0-C2BC07E6A706Q37242467-E056990E-54FB-4D4A-86C9-0B5EBE5041E6Q41637093-1848FD85-0644-4957-90A2-5FC1ECA0D1E2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathology and breast screening.
@en
Pathology and breast screening.
@nl
type
label
Pathology and breast screening.
@en
Pathology and breast screening.
@nl
prefLabel
Pathology and breast screening.
@en
Pathology and breast screening.
@nl
P1433
P1476
Pathology and breast screening.
@en
P2093
C W Elston
P304
P50
P577
1990-02-01T00:00:00Z